全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
化学进展  2014 

抗体药物偶联物

DOI: 10.7536/PC130650, PP. 467-477

Keywords: 抗体药物偶联物,链接,单抗,小分子药物

Full-Text   Cite this paper   Add to My Lib

Abstract:

单克隆抗体(单抗)药物是发展最为迅速的一个领域,在过去25年间大约有近30个单抗药物面世,主要用于抗癌和炎症;最近一种新的抗体药物偶联物(antibody-drugconjugate,ADC)技术取得了极大的成功。ADC是通过一个特殊的化学单元将单抗和小分子药物连接起来,充分利用抗体原有的亲合性和选择性,以及小分子药物的强药效,来降低小分子药物的毒性或延长小分子化合物的半衰期。随着一些链接技术的成熟和ADC药物上市,未来ADC将成为治疗疾病的重要手段。为了成功研制出一个新的ADC,需要对单抗、小分子药物和链接进行不断优化。一些新技术的问世也将极大促进ADC的发展。

References

[1]  Zolot R S, Basu S, Million R P. Nat. Rev. Drug Disc., 2013, 12: 259.
[2]  Teicher B A, Chari R V J. Clin. Cancer Res., 2011, 17 (20): 6389.
[3]  Hamblett K J, Senter P D, Chace D F, Sun M M C, Lenox J, Cerveny C G, Kissler K M, Bernhardt S X, Kopcha A K, Zabinski R F, Meyer D L, Francisco J A. Clin. Cancer Res., 2004, 10: 7063.
[4]  McDonagh C F, Turcott E, Westendorf L, Webster J B, Alley S C, Kim K, Andreyka J, Stone I, Hamblett K J, Francisco J A, Carter P. Prot. Eng. Des. Sel., 2006, 19: 299.
[5]  de Vries J F, Zwaan C M, De Bie M, Voerman J S A, den Boer M L, van Dongen J J M, van der Velden V H J. Leukemia, 2012, 26: 255.
[6]  Mullard A. Nat. Rev. Drug Disc., 2013, 12: 329.
[7]  Ducry L, Stump B. Bioconjugate Chem., 2010, 21: 5-13.
[8]  Dosio F, Brusa P, Cattel L. Toxins, 2011, 3: 848.
[9]  Beck A, Haeuw J F, Wurch T, Goetsch L, Bailly C, Corvaia N. Discov. Med., 2010, 10 (53): 329.
[10]  Govindan S V, Goldenberg D M. Sci. World J., 2010, 10: 2070.
[11]  Hitchcock S A. J. Med. Chem., 2012, 55: 4877.
[12]  Zhao R Y, Erickson H K, Leece B A, Reid E E, Goldmacher V S, Lambert J M, Chari R V J. J. Med. Chem., 2012, 55: 766.
[13]  Flygare J A, Pillow T H, Aristoff P. Chem. Biol. Drug Des., 2013, 81: 113.
[14]  Trail P A, Willner D, Lasch S J, Henderson A J, Hofstead S, Casazza A M, Firestone R A, Hellstrom I, Hellstrom K E. Science, 1993, 261: 212.
[15]  Dubowchik G M, Firestone R A, Padilla L, Willner D, Hofstead S J, Mosure K, Knipe J O, Lasch S J, Trail P A. Bioconjugate Chem., 2002, 13: 855.
[16]  Van der Velden V H J, te Marvelde J G, Hoogeveen P G, Bernstein I D, Houtsmuller A B, Berger M S, van Dongen J J M. Blood, 2001, 97: 3197.
[17]  Hamann P R, Hinman L M, Beyer C F, Lindh D, Upeslacis J, Shochat D, Mountain A. Bioconjugate Chem., 2005, 16: 354.
[18]  Ranson M, Sliwkowski M X. Oncology, 2002, 63: 17.
[19]  Widdison W C, Wilhelm S D, Cavanagh E E, Whiteman K R, Leece B A, Kovtun Y, Goldmacher V S, Xie H, Steeves R M, Lutz R J, Zhao R, Wang L, Blattler W A, Chari R V J. J. Med. Chem., 2006, 49: 4392.
[20]  Erickson H K, Park P U, Widdison W C, Kovtun Y V, Garrett L M, Hoffman K, Lutz R J, Goldmacher V S, Blattler W A. Cancer Res., 2006, 66: 4426.
[21]  Kovtun Y V, Audette C A, Ye Y, Xie H, Ruberti M F, Phinney S J, Leece B A, Chittenden T, Bl?ttler W A, Goldmacher V S. Cancer Res., 2006, 66: 3214.
[22]  Doronina S O, Toki B E, Torgov M Y, Mendelsohn B A, Cerveny C G, Chace D F, DeBlanc R L, Gearing R P, Bovee T D, Siegall C B, Francisco J A, Wahl A F, Meyer D L, Senter P D. Nat. Biotechnol., 2003, 21: 778.
[23]  Toki B E, Cerveny C G, Wahl A F, Senter P D. J. Org. Chem., 2002, 67: 1866.
[24]  Sanderson R J, Hering M A, James S F, Sun M M C, Doronina S O, Siadak A W, Senter P D, Wahl A F. Clin. Cancer Res., 2005, 11: 843.
[25]  Doronina S O, Bovee T D, Meyer D W, Miyamoto J B, Anderson M E, Morris-Tilden C A, Senter P D. Bioconjugate Chem., 2008, 19: 1960.
[26]  Doronina S O, Mendelsohn B A, Bovee T D, Cerveny C G, Alley S C, Meyer D L, Oflazoglu E, Toki B E, Sanderson R J, Zabinski R F, Wahl A F, Senter P D. Bioconjugate Chem., 2006, 17: 114.
[27]  Ban H, Nagano M, Gavrilyuk J, Hakamata W, Inokuma T, Barbas C F. Bioconjugate Chem., 2013, 24: 520.
[28]  Sato S, Inokuma T, Otsubo N, Burton D R, Barbas C F. ACS Med. Chem. Lett., 2013, 4: 460.
[29]  Casi G, Huguenin-Dezot N, Zuberbühler K, Scheuermann J, Neri D. J. Am. Chem. Soc., 2012, 134: 5887.
[30]  Goldmacher V S, Kovtun Y V. Ther. Deliv., 2011, 2 (3): 397.
[31]  Hamann P R, Hinman L M, Beyer C F, Lindh D, Upeslacis J, Flowers D A, Bernstein I. Bioconjugate Chem., 2002, 13: 40.
[32]  Hamann P R, Hinman L M, Hollander I, Beyer C F, Lindh D, Holcomb R, Hallett W, Tsou H R, Upeslacis J, Shochat D, Mountain A, Flowers D A, Bernstein I. Bioconjugate Chem., 2002, 13: 47.
[33]  Hollander I, Kunz A, Hamann P R. Bioconjugate Chem., 2008, 19: 358.
[34]  Ritter A. Pharm. Technol., 2012, 36 (1): 42.
[35]  Burris H A. Expert Opin. Biol. Ther., 2011, 11 (6): 807.
[36]  Xie H, Audette C, Hoffee M, Lambert J M, Blattler W A. J. Pharmacol. Exp. Ther., 2004, 308: 1073.
[37]  Koblinski J E, Ahram M, Sloane B F. Clin. Chim. Acta, 2000, 291: 113.
[38]  Jeffrey S C, Nguyen M T, Andreyka J B, Meyer D L, Doronina S O, Senter P D. Bioorg. Med. Chem. Lett., 2006, 16: 358.
[39]  Chari R V J. Acc. Chem. Res., 2008, 41: 98.
[40]  Polson A G, Calemine-Fenaux J, Chan P, Chang W, Christensen E, Clark S, de Sauvage F J, Eaton D, Elkins K, Elliott J M, Frantz G, Fuji R N, Gray A, Harden K, Ingle G S, Kljavin N M, Koeppen H, Nelson C, Prabhu S, Raab H, Ross S, Stephan J P, Scales S J, Spencer S D, Vandlen R, Wranik B, Yu S F, Zheng B, Ebens A. Cancer Res., 2009, 69: 2358.
[41]  Alley S C, Benjamin D R, Jeffrey S C, Okeley N M, Meyer D L, Sanderson R J, Senter P D. Bioconjugate Chem., 2008, 19: 759.
[42]  Jeffrey S C, Brabander J D, Miyamoto J, Senter P D. ACS Med. Chem. Lett., 2010, 1: 277.
[43]  Cal P M S D, Vicente J B, Pires E, Coelho A V, Veiros L F, Cordeiro C, Gois P M P. J. Am. Chem. Soc., 2012, 134: 10299.
[44]  Li L S, Rader C, Matsushita M, Das S, Barbas C F, Lerner R A, Sinha S C. J. Med. Chem., 2004, 47: 5630.
[45]  Voynov V, Chennamsetty N, Kayser V, Wallny H J, Helk B, Trout B L. Bioconjug. Chem., 2010, 21: 385.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133